By Jennifer Couzin-FrankelSep. 13, 2019 , 5:15 PM After 8 hours of contentious discussion, an advisory committee to the U.S. Food and Drug Administration (FDA) today endorsed the effectiveness of a first-of-its-kind peanut allergy treatment. By a seven-to-two vote, the panel concluded that the treatment, known as AR101, can reduce allergic reactions from accidental exposure to… Read More »
NOTE TO READERS: KHN’s First Edition will not be published July 4-5. Look for it again in your inbox July 8. Happy holidays! Kaiser Health News: Newly Blue Maine Expands Access To Abortion While abortion bans in Republican-led states dominated headlines in recent weeks, a handful of other states have expanded abortion access. Maine joined… Read More »
Today’s early morning highlights from the major news organizations. Kaiser Health News: Planned Parenthood’s ‘Risky Strategy’ To Update Its Image The Trump administration is pushing ahead with its reproductive health agenda. It has rolled out changes to the Title X program, which funds family planning services for low-income people, that are designed to have a… Read More »
“Drug prices in this country actually came down last year for the first time in 50 years. That’s because Donald Trump’s president.” Mick Mulvaney, April 7, 2019, on “Fox News Sunday” President Donald Trump announced last month that the GOP will become “the party of health care,” and news reports suggest he intends to make… Read More »